INNOVATORS

PENN MEDICINE

INFORMATICS

Penn Medicine has contributed through their Biomedical Informatics institute accomplishments of a sepsis early warning system and detecting patients with heart failure. Their primary goal is to "harness the power of big data to develop predictive analytics models and methods for spotting illnesses in their earliest stages, or even preventing them from occurring in the first place". (4.2)

GENOMENEXT

GenomeNext's dedication to expanding the capabilites of predictive medicine is shown through their continuous advancement in genomic analysis including their current examination of 2,504 individuals' whole genomes and exomes from 26 different populations in a single week, at 1,000 samples per day. (4.3)

GENENTECH

Genentech has made vast contribution to the field of Predictive Medicine, including their current research in oncology treatment. They are currently trying to apply personalized cancer immunotherapy (PCI) to those diagnosed with cancer. Genentech is studying more than 20 investigational medicines and evaluating genetic biomarkers. (4.4)

DUKE CLINICAL RESEARCH INSTITUTE

Duke's Center for Predictive Medicine (CPM) pinpoints the creation and application of disease profiling ot be utilized within electronic health records. The Duke Clinical Research Institute's CPM is currently the leading analytic center for the Southeaster Diabetes Initiative and for Duke's Center for Commmunity and Population Health Research. (4.5)

PREDICTIVE HEALTH INSTITUTE OF EMORY UNIVERSITY & GEORGIA TECH

The Predictive Health Institute of Emory and Georgia Tech holds a research core of a clinical testing foundation for predictive biomarkers of health, disease risk, and diagnosis with aims to maintain the healthiness of people. The programs of Emory University and Georgia Tech include anthropoogy, public health, and human genetics. (4.6)